Hodgkin's disease in patients with HIV infection

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Spina, Michele ^a   Carbone, Antonino ^a   Gloghini, Annunziata ^b   Serraino, Diego ^a   Berretta, Massimiliano ^a   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BUSULFAN; CYCLOPHOSPHAMIDE; DACARBAZINE; DIDANOSINE; DOXORUBICIN; EPIRUBICIN; NAVELBINE; PREDNISONE; VINBLASTINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK NEOPLASMS; HODGKIN DISEASE; HUMANS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78349273130     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/402682     Document Type: Review

References (64)

1. Bonnet F., Burty C., Lewden C., Costagliola D., May T., Bouteloup V., Rosenthal E., Jougla E., Cacoub P., Salmon D., Chne G., Morlat P., Changes in cancer mortality among HIV-infected patients: the Mortalit 2005 survey Clinical Infectious Diseases 2009 48 5 633 639
2. Serraino D., Dal Maso L., De Paoli A., Zucchetto A., Bruzzone S., Camoni L., Suligoi B., On changes in cancer mortality among HIV-infected patients: is there an excess risk of death from pancreatic cancer? Clinical Infectious Diseases 2009 49 3 481 482
3. Engels E. A., Pfeiffer R. M., Goedert J. J., Virgo P., McNeel T. S., Scoppa S. M., Biggar R. J., Trends in cancer risk among people with AIDS in the United States 19802002 AIDS 2006 20 12 1645 1654
4. Biggar R. J., Jaffe E. S., Goedert J. J., Chaturvedi A., Pfeiffer R., Engels E. A., Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS Blood 2006 108 12 3786 3791
5. Jaffe E. S., Harris N. L., Stein H., World Health Organization Classification of Tumours: Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues 2001 Lyon, France IARC Press
6. Swerdlow S. H., Campo E., Jaffe E. S., World Health Organization Classification of Tumours: Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues 2008 Lyon, France IARC Press
7. Grogg K. L., Miller R. F., Dogan A., HIV infection and lymphoma Journal of Clinical Pathology 2007 60 12 1365 1372
8. Tirelli U., Errante D., Dolcetti R., Gloghini A., Serraino D., Vaccher E., Franceschi S., Boiocchi M., Carbone A., Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors Journal of Clinical Oncology 1995 13 7 1758 1767
9. Curado M. P., Edwards B., Shin H. R., Cancer Incidence in Five Continents 2007 9 Lyon, France IARC IARC Scientific Publications, no. 160
10. Hjalgrim H., Askling J., Pukkala E., Hansen S., Munksgaard L., Frisch M., Incidence of Hodgkin's disease in Nordic countries The Lancet 2001 358 9278 297 298
11. Biggar R. J., Horm J., Goedert J. J., Melbye M., Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984 American Journal of Epidemiology 1987 126 4 578 586
12. Hessol N. A., Katz M. H., Liu J. Y., Buchbinder S. P., Rubino C. J., Holmberg S. D., Increased incidence of Hodgkin disease in homosexual men with HIV infection Annals of Internal Medicine 1992 117 4 309 311
13. Serraino D., Carbone A., Franceschi S., Tirelli U., Increased frequency of lymphocyte depletion and mixed cellularity subtypes of Hodgkin's disease in HIV-infected patients European Journal of Cancer A 1993 29 14 1948 1950
14. Serraino D., Pezzotti P., Dorrucci M., Alliegro M. B., Sinicco A., Rezza G., Cancer incidence in a cohort of human immunodeficiency virus seroconverters Cancer 1997 79 5 1004 1008
15. Franceschi S., Dal Maso L., Arniani S., Crosignani P., Vercelli M., Simonato L., Falcini F., Zanetti R., Barchielli A., Serraino D., Rezza G., Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy British Journal of Cancer 1998 78 7 966 970
16. Appleby P., Beral V., Newton R., Reeves G., Carpenter L., Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults Journal of the National Cancer Institute 2000 92 22 1823 1830
17. Grulich A. E., Li Y., McDonald A., Correll P. K. L., Law M. G., Kaldor J. M., Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis AIDS 2002 16 8 1155 1161
18. Dal Maso L., Franceschi S., Polesel J., Braga C., Piselli P., Crocetti E., Falcini F., Guzzinati S., Zanetti R., Vercelli M., Rezza G., Risk of cancer in persons with AIDS in Italy, 19851998 British Journal of Cancer 2003 89 1 94 100 (Pubitemid 36897942)
19. Herida M., Mary-Krause M., Kaphan R., Cadranel J., Poizot-Martin I., Rabaud C., Plaisance N., Tissot-Dupont H., Boue F., Lang J.-M., Costagliola D., Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients Journal of Clinical Oncology 2003 21 18 3447 3453
20. Clifford G. M., Polesel J., Rickenbach M., Maso L. D., Keiser O., Kofler A., Rapiti E., Levi F., Jundt G., Fisch T., Bordoni A., De Weck D., Franceschi S., Battegay M., Bernasconi E., Bni J., Bucher H., Brgisser P., Cattacin S., Cavassini M., Dubs R., Egger M., Elzi L., Erb P., Fantelli K., Fischer M., Flepp M., Fontana A., Francioli P., Furrer H., Gorgievski M., Gnthard H., Hirschel B., Kaiser L., Kind C., Klimkait T., Ledergerber B., Lauper U., Opravil M., Paccaud F., Pantaleo G., Perrin L., Piffaretti J.-C., Rudin C., Schmid P., Schpbach J., Speck R., Telenti A., Trkola A., Vernazza P., Weber R., Yerly S., Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy Journal of the National Cancer Institute 2005 97 6 425 432
21. Serraino D., Piselli P., Busnach G., Burra P., Citterio F., Arbustini E., Baccarani U., De Juli E., Pozzetto U., Bellelli S., Polesel J., Pradier C., Maso L. D., Angeletti C., Carrieri M. P., Rezza G., Franceschi S., Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe European Journal of Cancer 2007 43 14 2117 2123
22. Engels E. A., Biggar R. J., Hall H. I., Cross H., Crutchfield A., Finch J. L., Grigg R., Hylton T., Pawlish K. S., McNeel T. S., Goedert J. J., Cancer risk in people infected with human immunodeficiency virus in the United States International Journal of Cancer 2008 123 1 187 194
23. Powles T., Robinson D., Stebbing J., Shamash J., Nelson M., Gazzard B., Mandelia S., Mller H., Bower M., Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection Journal of Clinical Oncology 2009 27 6 884 890
24. Levine A. M., Hodgkin lymphoma: to the HAART of the matter Blood 2006 108 12 3630
25. Gloghini A., Carbone A., Why would the incidence of HIV-associated Hodgkin lymphoma increase in the setting of improved immunity? International Journal of Cancer 2007 120 12 2753 2754
26. Carbone A., Cabras A., Gloghini A., HIV-associated Hodgkin's lymphoma. Antiapoptotic pathways and mechanisms for immune escape by tumor cells in the setting of improved immunity International Journal of Biological Markers 2007 22 2 161 163
27. Dolcetti R., Boiocchi A., Gloghini A., Carbone A., Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease European Journal of Cancer 2001 37 10 1276 1287
28. Said J. W., Immunodeficiency-related hodgkin lymphoma and its mimics Advances in Anatomic Pathology 2007 14 3 189 194
29. Carbone A., Gloghini A., Larocca L. M., Antinori A., Falini B., Tirelli U., Dalla-Favera R., Gaidano G., Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells Blood 1999 93 7 2319 2326
30. Rezk S. A., Weiss L. M., Epstein-Barr virus-associated lymphoproliferative disorders Human Pathology 2007 38 9 1293 1304
31. Carbone A., Gloghini A., Dotti G., EBV-associated lymphoproliferative disorders: classification and treatment Oncologist 2008 13 5 577 585
32. Klein U., Dalla-Favera R., Germinal centres: role in B-cell physiology and malignancy Nature Reviews Immunology 2008 8 1 22 33
33. Vockerodt M., Morgan S. L., Kuo M., Wei W., Chukwuma M. B., Arrand J. R., Kube D., Gordon J., Young L. S., Woodman C. B., Murray P. G., The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype Journal of Pathology 2008 216 1 83 92
34. Tirelli U., Vaccher E., Serraino D., Bertola G., Saracchini S., Volpe R., Crovatto M., De Paoli P., Zagonel V., Monfardini S., Carbone A., Comparison of presenting clinical and laboratory findings of patients with persistent generalized lymphadenopathy (PGL) syndrome and malignant lymphoma (ML) Haematologica 1987 72 6 563 565
35. Andrieu J. M., Roithmann S., Tourani J. M., Levy R., Desablens B., Le Maignan C., Gastaut J. A., Brice P., Raphael M., Taillan B., Hodgkin's disease during HIV1 infection: the French registry experience Annals of Oncology 1993 4 8 635 641
36. Rubio R., Hodgkin's disease associated with human immunodeficiency virus infection: a clinical study of 46 cases Cancer 1994 73 9 2400 2407
37. Vaccher E., Spina M., Talamini R., Zanetti M., Di Gennaro G., Nasti G., Tavio M., Bernardi D., Simonelli C., Tirelli U., Improvement of systemic human immunodeficiency virus-related non-hodgkin lymphoma outcome in the era of highly active antiretroviral therapy Clinical Infectious Diseases 2003 37 11 1556 1564
38. Chimienti E., Spina M., Gastaldi R., Clinical characteristics and outcome of 290 patients (pts) with Hodgkin's disease and HIV infection (HD-HIV) in pre and HAART (highly active antiretroviral therapy) era Annals of Oncology 2008 19 iv136, abstract no. 168
39. Berenguer J., Miralles P., Ribera J. M., Rubio R., Valencia E., Mahillo B., Pintado V., Palacios R., Montes M. L., Tllez M. J., La Cruz J., Torre-Cisneros J., Rodrguez-Arrondo F., Seplveda M. A., Gutirrez F., Peralta G., Boix V., Characteristics and outcome of AIDS-related hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 2008 47 4 422 428
40. Errante D., Tirelli U., Gastaldi R., Milo D., Nosari A. M., Rossi G., Fiorentini G., Carbone A., Vaccher E., Monfardini S., Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection: a prospective study of 17 patients Cancer 1994 73 2 437 444
41. Errante D., Gabarre J., Ridolfo A. L., Rossi G., Nosari A. M., Gisselbrecht C., Kerneis Y., Mazzetti F., Vaccher E., Talamini R., Carbone A., Tirelli U., Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF Annals of Oncology 1999 10 2 189 195
42. Levine A. M., Li P., Cheung T., Tulpule A., Von Roenn J., Nathwani B. N., Ratner L., Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS Clinical Trials Group Study (ACTG 149) Journal of Acquired Immune Deficiency Syndromes 2000 24 5 444 450
43. Gastaldi R., Martino P., Gentile G., Picardi V., De Propris M. S., Pirillo M. F., De Vellis A., Mandelli F., Hodgkin's disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony-stimulating factor Annals of Oncology 2002 13 7 1158 1160
44. Spina M., Gabarre J., Rossi G., Fasan M., Schiantarelli C., Nigra E., Mena M., Antinori A., Ammassari A., Talamini R., Vaccher E., Di Gennaro G., Tirelli U., Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection Blood 2002 100 6 1984 1988
45. Hartmann P., Rehwald U., Salzberger B., Franzen C., Sieber M., Whrmann A., Diehl V., BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection Annals of Oncology 2003 14 10 1562 1569
46. Xicoy B., Ribera J.-M., Miralles P., Berenguer J., Rubio R., Mahillo B., Valencia M.-E., Abella E., Lpez-Guillermo A., Sureda A., Morgades M., Navarro J.-T., Esteban H., Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma Haematologica 2007 92 2 191 198
47. Xicoy B., Ribera J.-M., Romeu J., Mate J.-L., Mill F., Feliu E., Response to highly active antiretroviral therapy as the only therapy in an HIV-infected patient with interfollicular Hodgkin's lymphoma Leukemia and Lymphoma 2007 48 10 2058 2059
48. Spina M., Rossi G., Antinori A., VEBEP regimen and highly active antiretroviral therapy (HAART) in patients (pts) with HD and HIV infection (HD-HIV) Annals of Oncology 2008 19 iv152, abstract no. 227
49. Gabarre J., Marcelin A.-G., Azar N., Choquet S., Lvy V., Lvy Y., Tubiana R., Charlotte F., Norol F., Calvez V., Spina M., Vernant J.-P., Autran B., Leblond V., High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease Haematologica 2004 89 9 1100 1108
50. Re A., Cattaneo C., Michieli M., Casari S., Spina M., Rupolo M., Allione B., Nosari A., Schiantarelli C., Vigan M., Izzi I., Ferremi P., Lanfranchi A., Mazzuccato M., Carosi G., Tirelli U., Rossi G., High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy Journal of Clinical Oncology 2003 21 23 4423 4427
51. Krishnan A., Molina A., Zaia J., Smith D., Vasquez D., Kogut N., Falk P. M., Rosenthal J., Alvarnas J., Forman S. J., Durable remissions with autologous stem cell transplantation for high-risk HTV-associated lymphomas Blood 2005 105 2 874 878
52. Serrano D., Carrin R., Balsalobre P., Miralles P., Berenguer J., Buo I., Gmez-Pineda A., Ribera J. M., Conde E., Dez-Martn J. L., HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation Experimental Hematology 2005 33 4 487 494
53. Re A., Michieli M., Casari S., Allione B., Cattaneo C., Rupolo M., Spina M., Manuele R., Vaccher E., Mazzucato M., Abbruzzese L., Ferremi P., Carosi G., Tirelli U., Rossi G., High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors Blood 2009 114 7 1306 1313
54. Spitzer T. R., Ambinder R. F., Lee J. Y., Kaplan L. D., Wachsman W., Straus D. J., Aboulafia D. M., Scadden D. T., Dose-reduced Busulfan, Cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium Study 020 Biology of Blood and Marrow Transplantation 2008 14 1 59 66
55. Cheson B. D., Pfistner B., Juweid M. E., Gascoyne R. D., Specht L., Horning S. J., Coiffier B., Fisher R. I., Hagenbeek A., Zucca E., Rosen S. T., Stroobants S., Lister T. A., Hoppe R. T., Dreyling M., Tobinai K., Vose J. M., Connors J. M., Federico M., Diehl V., Revised response criteria for malignant lymphoma Journal of Clinical Oncology 2007 25 5 579 586
56. Juweid M. E., Stroobants S., Hoekstra O. S., Mottaghy F. M., Dietlein M., Guermazi A., Wiseman G. A., Kostakoglu L., Scheidhauer K., Buck A., Naumann R., Spaepen K., Hicks R. J., Weber W. A., Reske S. N., Schwaiger M., Schwartz L. H., Zijlstra J. M., Siegel B. A., Cheson B. D., Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma Journal of Clinical Oncology 2007 25 5 571 578
57. Gallamini A., Rigacci L., Merli F., Nassi L., Bosi A., Capodanno I., Luminari S., Vitolo U., Sancetta R., Iannitto E., Trentin L., Stelitano C., Tavera S., Biggi A., Castagnoli A., Versari A., Gregianin M., Pelosi E., Torchio P., Levis A., The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease Haematologica 2006 91 4 475 481
58. Hutchings M., Loft A., Hansen M., Pedersen L. M., Buhl T., Jurlander J., Buus S., Keiding S., D'Amore F., Boesen A.-M., Berthelsen A. K., Specht L., FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma Blood 2006 107 1 52 59
59. Weihrauch M. R., Manzke O., Beyer M., Haverkamp H., Diehl V., Bohlen H., Wolf J., Schultze J. L., Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor Cancer Research 2005 65 13 5516 5519
60. Just P.-A., Fieschi C., Baillet G., Galicier L., Oksenhendler E., Moretti J.-L., 18F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma AIDS Patient Care and STDs 2008 22 9 695 700
61. Goshen E., Davidson T., Avigdor A., Zwas T. S., Levy I., PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads Clinical Nuclear Medicine 2008 33 9 610 614
62. Barrington S. F., O'Doherty M. J., Limitations of PET for imaging lymphoma European Journal of Nuclear Medicine and Molecular Imaging 2003 30 supplement 1 S117 S127
63. Itti E., Lin C., Dupuis J., Paone G., Capacchione D., Rahmouni A., Haioun C., Meignan M., Prognostic value of interim18F-FDG PETin patients with diffuse large B-cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy Journal of Nuclear Medicine 2009 50 4 527 533
64. Meignan M., Gallamini A., Meignan M., Gallamini A., Haioun C., Report on the first international workshop on interim-PET-scan in lymphoma Leukemia Lymphoma 2009 50 8 1257 1260